First Hawaiian Bank acquired a new stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) in the 3rd quarter, HoldingsChannel reports. The institutional investor acquired 27,590 shares of the pharmacy operator’s stock, valued at approximately $2,012,000.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in WBA. Massachusetts Financial Services Co. MA bought a new position in shares of Walgreens Boots Alliance in the second quarter worth $199,228,000. LSV Asset Management boosted its holdings in shares of Walgreens Boots Alliance by 17.2% in the second quarter. LSV Asset Management now owns 8,704,233 shares of the pharmacy operator’s stock worth $522,384,000 after acquiring an additional 1,277,546 shares during the period. Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of Walgreens Boots Alliance by 11.5% in the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,110,617 shares of the pharmacy operator’s stock worth $666,804,000 after acquiring an additional 1,143,819 shares during the period. Burgundy Asset Management Ltd. boosted its holdings in shares of Walgreens Boots Alliance by 16.0% in the second quarter. Burgundy Asset Management Ltd. now owns 7,161,408 shares of the pharmacy operator’s stock worth $429,792,000 after acquiring an additional 986,275 shares during the period. Finally, Assenagon Asset Management S.A. boosted its holdings in shares of Walgreens Boots Alliance by 862.0% in the second quarter. Assenagon Asset Management S.A. now owns 1,040,549 shares of the pharmacy operator’s stock worth $62,449,000 after acquiring an additional 932,386 shares during the period. 61.92% of the stock is owned by institutional investors and hedge funds.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction dated Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the sale, the director now owns 10,943 shares in the company, valued at $722,128.57. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 14.80% of the company’s stock.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. The company had revenue of $33.44 billion for the quarter, compared to the consensus estimate of $33.64 billion. On average, analysts predict that Walgreens Boots Alliance Inc will post 5.98 EPS for the current year.
WBA has been the subject of a number of analyst reports. TheStreet raised Walgreens Boots Alliance from a “c+” rating to a “b” rating in a report on Wednesday, September 12th. BidaskClub upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Wednesday, July 18th. Loop Capital increased their price objective on Walgreens Boots Alliance to $80.00 and gave the stock a “buy” rating in a research report on Friday, June 29th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research report on Tuesday, September 25th. Finally, Barclays increased their price objective on Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Friday, October 12th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $78.22.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Recommended Story: Short Selling Stocks and Day Traders
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.